- Home
- KELYA vs KURA Comparison
KELYA vs KURA Comparison
Compare KELYA & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYA
- KURA
- Stock Information
- Founded
- KELYA 1946
- KURA 2014
- Country
- KELYA United States
- KURA United States
- Employees
- KELYA N/A
- KURA N/A
- Industry
- KELYA Professional Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KELYA Consumer Discretionary
- KURA Health Care
- Exchange
- KELYA Nasdaq
- KURA Nasdaq
- Market Cap
- KELYA 752.3M
- KURA 793.2M
- IPO Year
- KELYA N/A
- KURA N/A
- Fundamental
- Price
- KELYA $14.48
- KURA $7.39
- Analyst Decision
- KELYA Buy
- KURA Strong Buy
- Analyst Count
- KELYA 1
- KURA 11
- Target Price
- KELYA $25.00
- KURA $27.89
- AVG Volume (30 Days)
- KELYA 1.1M
- KURA 1.5M
- Earning Date
- KELYA 02-13-2025
- KURA 02-25-2025
- Dividend Yield
- KELYA 2.09%
- KURA N/A
- EPS Growth
- KELYA 80.11
- KURA N/A
- EPS
- KELYA 1.16
- KURA N/A
- Revenue
- KELYA $4,372,900,000.00
- KURA N/A
- Revenue This Year
- KELYA N/A
- KURA N/A
- Revenue Next Year
- KELYA $8.21
- KURA $233.30
- P/E Ratio
- KELYA $12.38
- KURA N/A
- Revenue Growth
- KELYA N/A
- KURA N/A
- 52 Week Low
- KELYA $12.68
- KURA $6.98
- 52 Week High
- KELYA $25.27
- KURA $24.17
- Technical
- Relative Strength Index (RSI)
- KELYA 55.64
- KURA 22.90
- Support Level
- KELYA $13.87
- KURA $7.02
- Resistance Level
- KELYA $14.35
- KURA $7.66
- Average True Range (ATR)
- KELYA 0.45
- KURA 0.33
- MACD
- KELYA 0.16
- KURA 0.10
- Stochastic Oscillator
- KELYA 80.87
- KURA 21.58
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.